APA (7th ed.) Citation

N, F., U, B., M, D., P, D., S, E., L, F., . . . F, S. (2019). Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine. The Journal of infectious diseases, 219(11), 1799. https://doi.org/10.1093/infdis/jiy743

Chicago Style (17th ed.) Citation

N, Folschweiller, et al. "Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine." The Journal of Infectious Diseases 219, no. 11 (2019): 1799. https://doi.org/10.1093/infdis/jiy743.

MLA (9th ed.) Citation

N, Folschweiller, et al. "Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine." The Journal of Infectious Diseases, vol. 219, no. 11, 2019, p. 1799, https://doi.org/10.1093/infdis/jiy743.